Document:

EX-10.27

 Exhibit 10.27 

DESCRIPTION OF NON-EMPLOYEE DIRECTOR COMPENSATION 

Effective as of January 1, 2017, Quintiles IMS Holdings, Inc. (the “Company”) revised its
Non-Employee Director Compensation Program, which is applicable to those directors who (i) are not employees of the Company and (ii) are not affiliated with the sponsor shareholders pursuant to the
Shareholders Agreement, dated as of May 3, 2016, among Quintiles IMS Holdings, Inc. and the shareholders identified therein (an “Independent Director”). 

Each Independent Director will receive an annual cash retainer of $100,000 to be paid quarterly and an equity retainer with a fair value of
$200,000, which will be granted annually. Under the Non-Employee Director Compensation Program, the annual equity grant will be payable in fully vested restricted stock units. 

The Company will pay (i) the chair of its Audit Committee a $30,000 annual retainer, (ii) the chair of its Leadership Development
and Compensation Committee a $25,000 annual retainer, and (iii) the chair of its Nominating and Governance Committee a $20,000 annual retainer, each to be paid quarterly. The Company will pay (a) the members of its Audit Committee an
additional $10,000 annual retainer, and (b) the members of its Leadership Development and Compensation and Nominating and Governance Committee an additional $5,000 annual retainer, each to be paid quarterly. The Company will reimburse
reasonable travel expenses and other out-of-pocket costs incurred in connection with attendance at board of director meetings and committee meetings by each of the
Independent Directors.EX-10.41

 Exhibit 10.41 

Name of Participant:
                                         
                  
 QUINTILES IMS HOLDINGS, INC.

 2013 STOCK INCENTIVE PLAN 

AWARD AGREEMENT 

(Awarding Stock Appreciation Rights) 

THIS AWARD AGREEMENT (this “Agreement”) is made by and between Quintiles IMS Holdings, Inc., a Delaware corporation (the
“Company”), and the Participant named above (the “Participant”) pursuant to the provisions of the Quintiles IMS Holdings, Inc. 2013 Stock Incentive Plan (the “Plan”), which is incorporated herein by reference. 

WITNESSETH: 
 WHEREAS, the
Participant is providing, or has agreed to provide, services to the Company, or Affiliate or a Subsidiary of the Company, as an Employee, Director or Third Party Service Provider; and 

WHEREAS, the Company considers it desirable and in its best interests that the Participant be given a personal stake in the Company’s
growth, development and financial success through the grant of Stock Appreciation Rights (“SARs”) that may be exercised with respect to all or a portion of the number of whole common stock of the Company (“Shares”) set forth on
Exhibit A hereto, subject to the terms and conditions set forth in this Award Agreement and in the Plan. 
 NOW, THEREFORE, in consideration
of the premises and the mutual agreements set forth herein, the parties agree as follows: 
 1. Grant of SAR. Pursuant to the Plan, the
Company has granted to the Participant, on the grant date listed on Exhibit A hereto (the “Grant Date”), SARs that may be exercised with respect to all or a portion of the number of whole Shares set forth on Exhibit A hereto, subject to
the terms and conditions set forth in this Agreement and in the Plan. For the avoidance of doubt, the total number of Shares underlying the SARs is subject to adjustment pursuant to Section 4.4 of the Plan. The future value of such Shares is
unknown and cannot be predicted with certainty. If such Shares do not increase in value, the SAR will have no value. For purposes of this Agreement, “Employer” shall mean the Affiliate or Subsidiary that employs the Participant (to the
extent the Participant is not directly employed by the Company). 
 2. Nature of SAR. The SARs provide to the Participant a right to
receive, upon exercise of vested SARs in compliance with this Agreement, payment in Shares. The number of Shares that shall be delivered to the Participant upon a valid exercise of the SARs, before any reduction for withholding taxes in accordance
with Section 15, shall be determined by multiplying (i) times (ii) and dividing the resulting product by (iii), where: 
  

	 	(i)	is the number of SARs being exercised; 

	 	(ii)	is the excess of (A) the Fair Market Value of one (1) Share on the date of exercise, over (B) the “Grant Price” per Share set forth on Exhibit A; and 

 

	 	(iii)	is the Fair Market Value of one (1) Share on the date of exercise. 

 Unless otherwise
determined by the Company, no fractional Shares will be issued in payment upon the exercise of the SARs. 
 3. Term of SAR. Subject to
earlier termination under Section 5 hereof or pursuant to the Plan, the term of the SAR shall be the expiration date specified on Exhibit A hereto (the “Expiration Date”). 

4. Use of Certain Defined Terms. Capitalized terms used in this Agreement shall have the meaning specified in the Plan, unless a different
meaning is specified herein. In the event of a conflict between the terms and conditions of this Agreement and the Plan, the Plan shall control, except as expressly provided in Section 4 herein. The terms set forth below shall have the
following meanings: 
  

	 	(a)	“Disability” shall mean: (i) If the Participant is a party to an employment or severance-benefit agreement that contains a definition of “Disability,” the definition set forth in such agreement
shall apply with respect to the Participant under the Plan for so long as such agreement is in effect; and (ii) otherwise, a disability that would entitle the Participant to long-term disability benefits under the Company’s long-term
disability plan in which the Participant participates. 

  

	 	(b)	“Employment” shall mean the Participant’s employment by, or service to, the Company or any of its Subsidiaries. 

  

	 	(c)	“Retirement” shall mean retirement from active Employment after attaining age 65, or after attaining age 55 and completion of at least five (5) years of Employment with the Company or any of its
subsidiaries (including any acquired entity with respect to which the Committee has determined to credit pre-acquisition service for this purpose. 

5. Termination of SAR. Except as otherwise provided herein, the SAR shall terminate on the earliest to occur of the following: 

 

	 	(a)	The Expiration Date. 

  

	 	(b)	The 91st day after termination of the Participant’s service relationship for any reason other than one specified in (c) or (d) below. 

 

	 	(c)	The 366th day after termination of the Participant’s service relationship as a result of the Participant’s death, or a Disability, Retirement or
redundancy that is approved by the Committee for this purpose. 

  

	 	(d)	Termination of the Participant’s service relationship by the Company for Cause, or of the Participant’s service relationship by the Company or the Company or his or her Employer for reasons that would
constitute Cause if the Participant were an employee. 

 6. Vesting Schedule. Except as set forth below or in the Plan, the SARs shall become vested on
the vesting dates set forth on Exhibit A hereto, subject to the Participant’s continued Employment through the applicable vesting date. 

In no event will any portion of the SAR that is not vested and exercisable at the time of the termination of the Participant’s service
relationship become vested and exercisable following such termination. Further, notwithstanding any provision of the Plan or this Agreement to the contrary, in no event will any portion of the SAR that is not vested and exercisable immediately prior
to the time of a Sale of the Company become vested and exercisable because of such event. 
 7. Exercise of SAR. The Participant may
exercise vested SARs by giving notice (in such manner as is acceptable to the Company) to the Company of his or her election to exercise such SARs. This Notice shall set forth the number of Shares with respect to which the SAR is being exercised.
For the avoidance of doubt, the Company may in its sole discretion establish alternative means to exercise vested SARs, including electronic forms using electronic signatures and interactive voice response systems using PIN numbers, in a manner
directed by the Company, and the SARs shall be deemed to be exercised upon fulfillment of such alternative means. 
 Promptly following the
date the SARs are exercised, payment shall be made to the Participant in Shares, in accordance with Section 2. Payment may be made by issuance of Shares in the name of the Participant and delivery of such Shares to the Participant or, in the
discretion of the Company, by issuance and delivery of such Shares to a financial institution for the account of the Participant, or in any other commercially reasonable manner as may be determined by the Company. 

8. Cash Settlement. Notwithstanding any provision in this Agreement to the contrary, the Company may, in its sole discretion, settle the
Participant’s SARs in the form of (1) a cash payment to the extent settlement in Shares (i) is prohibited under local law, or (ii) would require the Participant, the Company and/or the Employer to obtain the approval of any
governmental and/or regulatory body in the Participant’s country of residence (and/or country of employment, if different), or (iii) is administratively burdensome; or (2) Shares, but require the Participant to immediately exercise
and sell such Shares (in which case, as a condition to the grant of this award, the Participant hereby expressly and explicitly authorizes the Company to issue sales instructions, on the Participant’s behalf) to any brokerage firm and/or third
party administrator engaged by the Company to hold your Shares and other amounts acquired under the Plan. 
 9. Non-Transferability of SARs. The SARs may not be transferred in any manner otherwise than by will or the laws of descent and distribution and, during the Participant’s lifetime, may only be exercised by the
Participant, and following the Participant’s death, only by the Participant’s legal representative or legatee, and, if the Committee permits a transfer of the SARs, by the permitted transferee. A permitted transferee will have the rights
of the Participant with regard to any transferred SARs, subject to any limitations imposed by the Company as a condition of permitting the transfer or otherwise. 

 10. Restrictions on Shares. This Agreement shall be subject to all applicable laws, rules, and
regulations, and to such approvals by any governmental agencies or stock exchange as may be required.    The Participant agrees to take all steps the Committee determines are necessary to comply with all applicable provisions of
federal, state and foreign securities law in exercising his or her rights under this Agreement. The Committee may impose such restrictions on any Shares acquired pursuant to the exercise of this SAR as it deems advisable, including, without
limitation, minimum holding period requirements, restrictions under applicable federal securities laws, under the requirements of any stock exchange or market upon which such Shares are then listed and/or traded, or under any blue sky state or
foreign securities laws as may be applicable to such Shares. 
 11. Forfeiture; Recovery of Compensation. 

 

	 	(a)	The Committee may cancel, rescind, withhold or otherwise limit or restrict the SARs or delivery of Shares upon exercise of the SARs at any time if the Participant is not in compliance with all applicable provisions of
this Agreement and the Plan. 

  

	 	(b)	By accepting the SARs, the Participant expressly acknowledges and agrees that his or her rights, and those of any permitted transferee of the SARs, under the SARs, including to any Shares acquired under the SARs or
proceeds from the disposition thereof, are subject to Section 11.3 and 20.19 of the Plan (including any successor provisions). 

  

	 	(c)	To the extend the Participant is covered by the Quintiles IMS Holdings Inc. Change in Control Severance Plan (the “Severance Plan”), adopted on November 5, 2015: Upon a termination of the
Participant’s employment or service with the Company, the effect of such termination of employment or service on the SARs shall be as set forth in this Agreement, and by accepting this SARs, the Participant expressly acknowledges and agrees
that the treatment of equity awards upon a termination of employment or service set forth in Section 5.01 of the Severance Plan, shall not in any respect apply to the SARs granted hereunder. 

12. Other Undertakings. To protect the interests of the Company and its direct and indirect affiliates and subsidiaries (individually, a
“QuintilesIMS Company” and collectively, the “QuintilesIMS Companies”), including the confidential information of the QuintilesIMS Companies and the confidential information of their respective customers, data suppliers,
prospective customers and other companies with which the QuintilesIMS Companies have a business relationship, and in consideration of the covenants and promises and other valuable consideration described in this Agreement, the Company and the
Participant agree as follows: 
  

	 	(a)	The Participant acknowledges and agrees that he or she is bound by the confidentiality and other covenants contained in one or more restrictive covenant and confidentiality agreements that he or she has executed with a
QuintilesIMS Company, which covenants and agreements are incorporated herein by reference and shall survive any exercise, expiration, forfeiture or other termination of this Agreement or the SARs issuable hereunder. The Participant also acknowledges
and agrees that the Company shall be an affiliate for purposes of such restrictive covenant and confidentiality agreements. 

	 	(b)	The Participant acknowledges that the opportunity to participate in the Plan and the financial benefits that may accrue from such participation, is good, valuable and sufficient consideration for the following:

  

	 	(i)	The Participant acknowledges and agrees that he or she is and will remain bound by the non-competition, non-solicitation and other
covenants contained in the restrictive covenant and confidentiality agreement(s) that he or she has executed with any of the QuintilesIMS Companies to the fullest extent permitted by law. 

 

	 	(ii)	The Participant further acknowledges and agrees that the period during which the non-competition and non-solicitation covenants in such
agreement(s) will apply following a termination of Employment shall be extended from twelve (12) months to eighteen (18) months; provided, however, that the remedies available for breach of any
non-competition or non-solicitation covenants during such extended six-month period shall be limited to the following:
(x) to the extent then outstanding, the forfeiture of the SARs for no consideration, and (y) to the extent the SARs have been exercised on or after the date that is 18 months before Participant’s cessation of Employment, with respect
to the Shares issued upon such exercise (including Shares withheld for taxes), the Participant shall pay to the Company an amount equal to (A) the aggregate Fair Market Value of such Shares as of the date of exercise, plus (B) the excess,
if any, of the aggregate proceeds of all sales of such Shares over the amount described under subsection (A) above. (For this purpose, the Participant’s earliest sales of Shares following such exercise will be deemed sales of the Shares
acquired upon such exercise.) The Company shall also be entitled to the foregoing remedies in the event of a material breach of any confidentiality, non-disclosure or other similar covenant contained in the
restrictive covenant and confidentiality agreement(s) that the Participant has executed with a QuintilesIMS Company. 

  

	 	(iii)	The Participant further acknowledges and agrees to the Company’s application, implementation and enforcement of (a) such policy set forth in Section 11(b)(ii) of this Agreement and (b) Section 20.19
of the Plan and any provision of applicable law, stock exchange rule or Company policy relating to cancellation, recoupment, rescission or payback of compensation and expressly agrees that the Company may take such actions as are necessary to
effectuate such policy (as applicable to the Participant) or applicable law or stock exchange rule without further consent or action being required by the Participant. For purposes of the foregoing, the Participant expressly and explicitly
authorizes the Company to issue instructions, on the Participant’s behalf, to any brokerage firm and/or third party administrator engaged by the Company to hold Participant’s Shares and other amounts acquired under the Plan to re-convey, transfer or otherwise return such Shares and/or other amounts to the Company. To the extent that the terms of this Agreement and such policy conflict, the terms of such policy shall prevail.

  

	 	(iv)	 By accepting the SARs, the Participant consents to one or more deductions from any amounts any QuintilesIMS
Company owes the Participant from time 

	 	
to time in an aggregate amount equal to all amounts described in subsection (ii) above, to the extent such deductions are permitted by applicable law. Any such deduction from an amount that
constitutes a deferral of compensation under Code Section 409A may only take place at the time the amount would otherwise be payable to the Participant, except to the extent permitted by Code Section 409A. 

13. Successors and Assigns. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement
shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth, the terms and conditions of the Plan and this Agreement shall be binding upon the Participant and his or her heirs,
executors, administrators, successors and assigns. 
 14. Interpretation. Any dispute regarding the interpretation of this Agreement shall
be submitted by the Participant or by the Company forthwith to the Committee, which shall review such dispute at its next regular meeting. The resolution of such a dispute by the Committee shall be final and binding on all parties. 

15. Tax Consequences. The exercise of this SAR and the subsequent disposition of the Shares may cause the Participant to be subject to
federal, state and/or non-U.S. taxation. The Participant should consult a tax advisor before exercising SARs or disposing of the Shares purchased hereunder. 

Regardless of any action the Company and/or the Employer takes with respect to any or all income tax (including U.S. federal, state and local
taxes and/or non-U.S. taxes), social insurance, payroll tax, payment on account or other tax-related withholding
(“Tax-Related Items”), the Participant acknowledges that the ultimate liability for all Tax-Related Items legally due by the Participant is and remains the
Participant’s responsibility and that the Company and the Employer (a) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the SARs, including the grant of the SARs, the
vesting of the SARs, the exercise of the SARs, the subsequent sale of any Shares acquired pursuant to the SARs and the receipt of any dividends and (b) do not commit to structure the terms of the grant or any aspect of the SARs to reduce or
eliminate the liability for Tax-Related Items. 
 Prior to the delivery of Shares upon exercise of
the SARs, if the Participant’s country of residence (and/or the Participant’s country of employment, if different) requires withholding of Tax-Related Items, unless otherwise determined by the
Committee, the Company shall withhold a sufficient number of whole Shares otherwise issuable upon exercise of the SARs that have an aggregate Fair Market Value sufficient to pay the Tax-Related Items required
to be withheld with respect to the Shares delivered upon such exercise of the SARs. The cash equivalent of the Shares withheld will be used to settle the obligation to withhold the Tax-Related Items. In the
event that withholding in shares is prohibited or problematic under applicable law or otherwise may trigged adverse consequences to the Company or the Employer, the Company and/or the Employer may withhold the minimum
Tax-Related Items required to be withheld with respect to the Shares in cash from the Participant’s regular salary and/or wages, or other amounts payable to the Participant. In the event the withholding
requirements are not satisfied through the 

 
withholding of Shares or through the Participant’s regular salary and/or wages or any other amounts payable to the Participant by the Employer, no Shares will be issued to the Participant
(or the Participant’s estate) upon exercise of the SARs unless and until satisfactory arrangements (as determined by the Committee) have been made by the Participant with respect to the payment of any
Tax-Related Items that the Company or the Employer determines, in its sole discretion, must be withheld or collected with respect to such SARs. By accepting the SARs, the Participant expressly consents to the
withholding of Shares and/or withholding from the Participant’s regular salary and/or wages or other amounts payable to the Participant as provided for hereunder. All other Tax-Related Items related to
the SARs and any Shares delivered in payment thereof are the Participant’s sole responsibility. 
 16. Participant Data Privacy. As a
condition of the grant of the SARs, the Participant consents to the collection, use and transfer of personal data as described in this paragraph. The Participant understands that the Company and its Affiliates or Subsidiaries hold certain personal
information about the Participant, including but not limited to the Participant’s name, home address, email address and telephone number, date of birth, social security number, passport or other identification number, salary, nationality, job
title, shares of common stock or directorships held in the Company, details of all SARs or other entitlement to shares of common stock awarded, cancelled, exercised, vested, unvested or outstanding in the Participant’s favor for the purpose of
managing and administering the Plan (“Data”). The Participant further understands that the Company and/or its Affiliates or Subsidiaries will transfer Data amongst themselves as necessary for the purposes of implementation, administration
and management of the Participant’s participation in the Plan, and that the Company and/or any of its Affiliates or Subsidiaries may each further transfer Data to any third parties assisting the Company in the implementation, administration and
management of the Plan. The Participant understands that these recipients may be located in the Participant’s country of residence or elsewhere. The Participant authorizes them to receive, possess, use, retain and transfer Data in electronic or
other form, for the purposes of implementing, administering and managing the Participant’s participation in the Plan, including any requisite transfer of such Data as may be required for the administration of the Plan and/or the subsequent
holding shares of common stock on the Participant’s behalf to a broker or other third party with whom the shares acquired on exercise may be deposited. 

The Participant understands that the Participant may, at any time, view Data, request information about the storage and processing of Data,
require any amendments to Data or refuse or withdraw the consent herein, in any case without cost, by contacting in writing the human resources representative. Further, the Participant does not consent, or if the Participant later seeks to revoke
his or her consent, the Participant’s employment status or service with his or her Employer will be unaffected; the only consequence of refusing or withdrawing the Participant’s consent is that the Company would be unable to administer or
maintain the awards. Therefore, the Participant understands that refusing or withdrawing his or her consent may affect his or her ability to receive Awards and participate in the Plan. For more information on the consequences of the
Participant’s refusal to consent or withdrawal of consent, the Participant understands that the Participant may contact his or her local human resources representative. 

17. Confidentiality. The Participant agrees not to disclose the terms of this Agreement to anyone other than the members of the
Participant’s immediately family or the Participant’s counsel or financial advisors and agrees to advise such persons of the confidential nature of this offer. 

 18. Section 409A; No Deferral of Compensation. Neither the Plan nor this Agreement is intended to
provide for the deferral of compensation within the meaning of Section 409A of the Internal Revenue Code (the “Code”). The Company reserves the right to unilaterally amend or modify this Agreement, to the extent the Company considers it
necessary or advisable, in its sole discretion, to comply with, or to ensure that the SARs granted hereunder are not subject to, Section 409A of the Code. 

19. Governing Law. This Agreement and all claims arising out of or based upon this Agreement or relating to the subject matter hereof shall be
governed by and construed in accordance with the domestic substantive laws of the State of Delaware without giving effect to any choice or conflict of laws provision or rule that would cause the application of the domestic substantive laws of any
other jurisdiction. 
 Any legal proceeding arising out of this Plan or this Agreement shall be brought exclusively in the Federal or State
courts located in the State of Delaware. The Participant agrees to submit to personal jurisdiction and to venue in those courts. The Participant further agrees to waive all legal challenges and defenses to the appropriateness of Delaware as the site
of any such legal proceeding and to the application of the laws of the State of Delaware and any applicable Federal laws. 
 20.
Miscellaneous. 
  

	 	(a)	Notice hereunder shall be given to the Company at its principal place of business, and shall be given to the Participant at the last address shown in the Company’s records, or in either case at such other address
as one party may subsequently furnish to the other party in writing. 

  

	 	(b)	Notwithstanding any provisions of this Agreement to the contrary, the SARs shall be subject to any special terms and conditions for the Participant’s country of residence (and/or country of employment, if
different) set forth in the addendum to this Agreement (the “Addendum”). Further, if the Participant transfers residency and/or employment to another country set forth in the Addendum, at the time of transfer, any special terms and
conditions for such country will apply to the Participant to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable in order to comply with local law, rules and
regulations or to facilitate the operation and administration of the SARs and the Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate the Participant’s transfer). In all
circumstances, any applicable Addendum shall constitute part of this Agreement. 

  

	 	(c)	 The Company reserves the right to impose other requirements on the SARs, any Shares acquired pursuant to the SARs
and the Participant’s participation in the Plan to the extent the Company determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local law, rules and regulations or to facilitate the
operation and administration of the SARs and the 

	 	
Plan. Such requirements may include (but are not limited to) requiring the Participant to sign any agreements or undertakings that may be necessary to accomplish the foregoing. 

 

	 	(d)	The issuance of Shares upon exercise of the SARs will be contingent upon the Company’s receipt of any agreement, statement or other evidence that the Company and/or the Committee may require to satisfy itself that
the issuance of Shares pursuant to the exercise of the SARs and any subsequent resale of the Shares will be in compliance with all applicable laws and regulations and with the requirements hereof and of the Plan. The determination of the Committee
as to such compliance shall be final and binding on the Participant. The Participant shall not be deemed to be the holder of, or to have any dividend or other rights of a holder with respect to, any Shares subject to the SARs unless and until the
SARs shall have been exercised pursuant to the terms hereof and of the Plan, the Company shall have issued and delivered the Shares to the Participant in accordance with this Agreement, and the Participant’s name shall have been entered as the
shareholder of record on the books of the Company (if an alternative method of delivery is elected by the Company, the Participant will be required to take appropriate steps to cause any nominee to transfer shares into the name of the Participant in
order for the Participant to become a record holder of the shares). Thereupon, the Participant shall have full voting, dividend and other ownership rights with respect to such Shares. 

 

	 	(e)	This Agreement is subject in its entirety to the provisions of the Plan, which are incorporated herein by reference. A copy of the Plan as in effect on the Grant Date has been furnished to the Participant. By accepting
this award of SARs, the Participant agrees to be bound by the terms of the Plan and this Agreement. 

  

	 	(f)	This Agreement, the Addendum (if applicable) and the Plan constitute the entire understanding between the Participant and the Company regarding the SARs, and any prior agreements, commitments or negotiations concerning
the SARs are superseded. 

  

	 	(g)	Any provision of this Agreement or the Addendum that is deemed invalid, illegal or unenforceable in any jurisdiction shall, as to that jurisdiction and subject to this Section, be ineffective to the extent of such
invalidity, illegality or unenforceability, without affecting in any way the remaining provisions thereof in such jurisdiction or rendering that or any other provisions of this Agreement and the Addendum invalid, illegal, or unenforceable in any
other jurisdiction. If any covenant should be deemed invalid, illegal or unenforceable because its scope is considered excessive, such covenant shall be modified so that the scope of the covenant is reduced only to the minimum extent necessary to
render the modified covenant valid, legal and enforceable. No waiver of any provision or violation of this Agreement or the Addendum by the Company shall be implied by the Company’s forbearance or failure to take action. 

 21. Acknowledgement and Acceptance. 

 

	 	(a)	In accepting the SARs, the Participant acknowledges and agrees: (i) that the Plan is discretionary in nature and may be amended, cancelled, suspended or terminated by the Company at any time; (ii) that the
grant of the SARs does not create any contractual or other right to receive future grants of SARs or any right to continue an employment or other relationship with the Company (for the vesting period or otherwise); (iii) that the Participant
remains subject to discharge from such relationship to the same extent as if the SARs had not been granted; (iv) that all determinations with respect to any such future grants, including, but not limited to, when and on what terms they shall be
made, will be at the sole discretion of the Committee; (v) that participation in the Plan is voluntary; (vi) that the value of the SARs is an extraordinary item of compensation that is outside the scope of the Participant’s employment
contract if any; and (vii) that the grant of SARs is not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement
benefits or similar benefits. 

  

	 	(b)	If the Participant does not want to accept the SARs on the terms and conditions set out in this Agreement, the Plan and/or any related documents, the Participant may choose the “Decline” button. The SARs will
then be cancelled and no other benefit will be due to the Participant in lieu thereof. If Participant does not “Decline” the SARs within thirty (30) days from the Grant Date, the Participant shall be deemed to have accepted the SARs
and shall be deemed to have agreed to the terms and conditions set out in this Agreement, the Plan and/or any related documents. 

  

	 	(c)	All questions arising under this Agreement, Exhibit A, the Addendum (if applicable) and the Plan shall be decided by the Committee in its sole discretion. 

 

	 	(d)	The grant of the SAR is not intended to be a public offering of securities in the Participant’s country of residence (and country of employment, if different). The Company has not submitted any registration
statement, prospectus or other filings with the local securities authorities (unless otherwise required under local law), and the grant of the SARs is not subject to the supervision of the local securities authorities. No employee of the Company or
any of the Company’s subsidiaries is permitted to advise the Participant on whether the Participant should acquire Shares by exercising the SAR under the Plan. Investment in Shares involves a degree of risk. Before deciding to acquire Shares by
exercising the SARs, the Participant should carefully consider all risk factors relevant to the acquisition of Shares under the Plan and the Participant should carefully review all of the materials related to the SAR and the Plan. In addition, the
Participant should consult with the Participant’s personal advisor for professional investment advice. 

  

	 	(e)	The Participant acknowledges and agrees that it is the Participant’s express intent that this Agreement, the Exhibit A, the Addendum (if applicable) and the Plan and all other documents, notices and legal
proceedings entered into, given or instituted pursuant to the award, be drawn up in English. If the Participant has received this Agreement, the Exhibit A, the Addendum and the Plan or any other documents related to the award translated into a
language other than English, and if the meaning of the translated version is different than the English version, the English version shall control. 

	 	(f)	As a condition to the grant of the SARs, the Participant agrees to repatriate all payments attributable to the Shares and/or cash acquired under the Plan in accordance with local foreign exchange rules and regulations
in the Participant’s country of residence (and country of employment, if different). In addition, the Participant also agrees to take any and all actions, and consents to any and all actions taken by the Company and its affiliates and
subsidiaries and/or the Employer, as may be required to allow the Company and its affiliates and subsidiaries or the Employer to comply with local laws, rules and regulations in the Participant’s country of residence (and country of employment,
if different). Finally, the Participant agrees to take any and all actions as may be required to comply with the Participant’s personal obligations under local laws, rules and regulations in the Participant’s country of residence (and
country of employment, if different). 

 By choosing the “Accept” button, the Participant accepts the SARs as described above
and the terms and conditions set out in this Agreement, the Plan and any related documents. Copies of the Plan and such related documents are being provided to Participant as part of this Agreement. 

PARTICIPANT 
 [insert Name of Participant] 

QUINTILES IMS HOLDINGS, INC. 
  

	
	

	
	James H. Erlinger, III
	EVP, General Counsel & Corporate Secretary

 STOCK APPRECIATION RIGHTS AGREEMENT 

PURSUANT TO QUINTILES IMS HOLDINGS, INC. 

2013 STOCK INCENTIVE PLAN 

EXHIBIT A 
  

			
	Name of Participant:	  	[insert Name of Participant]
		
	 No. of Shares subject to the Stock
	  	
	Appreciation Rights:	  	[insert No. of Shares]
		
	Grant Price per Share:	  	$[insert per share grant price]
		
	Grant Date:	  	[insert Grant Date]
		
	Expiration Date:	  	[insert date 10 years from Grant Date]

 Vesting Schedule: 
  

							
	 Number of

SARs Exercisable
	 	Vesting Date	 
	[            ]	 	(33.00%)	 	 	[            	] 
	[            ]	 	(33.00%)	 	 	[            	] 
	[            ]	 	(34.00%)	 	 	[            	]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00266-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00266-of-00352.parquet"}]]